1. Wiegerinck JI. et al "Eponyms of the Kager triangle" J Bone Joint Surg Am. 2012 May 16;94(10):e67
2. Stoler A. et al "Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation" Proc. Natl. Acad. Sci. U.S.A. 1985 Jan;82(2)570-574
4. Bashiri FA. "Childhood epilepsies: What should a pediatrician know?" Neurosciences (Riyadh). 2017 Jan;22(1):14-19
5. Holcomb IN. et al "FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family" EMBO J. 2000 Aug 1;19(15):4046-55
6. Laitinen T. et al "Characterization of a common susceptibility locus for asthma-related traits" Science 2004 Apr;304(5668)300-304
7. Oguma T. et al "Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma" Allergol Int. 2008 Dec;57(4):307-12
8. Zedan MM. et al "Clinical asthma phenotyping: A trial for bridging gaps in asthma management" World J Clin Pediatr. 2015 May 8;4(2):13-8
9. Sarkar M. et al "Mechanisms of hypoxemia" Lung India. 2017 Jan-Feb;34(1):47-60
10. Kianmehra M. et al "Possible therapeutic effects of Crocus sativus stigma and its petal flavonoid, kaempferol, on respiratory disorders" Pharm Biol 2020; 58(1): 1140–1149
11. Hestvik AL. "The double-edged sword of autoimmunity: lessons from multiple sclerosis" Toxins (Basel). 2010 Apr;2(4):856-77
12. Beck J. et al "Serum DNA motifs predict disease and clinical status in multiple sclerosis" J Mol Diagn. 2010 May;12(3):312-9
13. Solari A. et al "Aminopyridines for symptomatic treatment in multiple sclerosis" Cochrane Database Syst Rev. 2001;(4):CD001330
14. Ford C. et al "Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate" Mult Scler. 2010 Mar;16(3):342-50
15. Paris D. et al "Amelioration of experimental autoimmune encephalomyelitis by anatabine" PLoS One. 2013;8(1):e55392
16. Skripuletz T. et al "Pivotal role of choline metabolites in remyelination" Brain. 2015 Feb;138(Pt 2):398-413
17. Nazari F. et al "Comparing the effects of reflexology and relaxation on fatigue in women with multiple sclerosis" Iran J Nurs Midwifery Res. 2015 Mar-Apr;20(2):200-4
18. Berrettini W. "Genetics of major mood disorders" Psychiatry (Edgmont). 2004 Sep;1(2):38-48
19. Cichon S. et al "Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorde" Am J Hum Genet. 2011 Mar 11;88(3):372-81
20. McClure D. et al "A Pilot Study of Safety and Efficacy of Cranial Electrotherapy Stimulation in Treatment of Bipolar II Depression" J Nerv Ment Dis. 2015 Nov;203(11):827-35
21. Barbanti-Brodano G. et al "BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors" Adv Exp Med Biol. 2006;577:319-41
22. Patel DK. "An overview on antidiabetic medicinal plants having insulin mimetic property" Asian Pac J Trop Biomed 2012 Apr;2(4):320-30
23. Lawrie SM. et al "Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk" Schizophr Bull. 2008 Mar;34(2):330-40
24. Lu J. et al "Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models" Neurosci Lett 2018 Nov 20;687:104-110
25. Young IS. et al "Antioxidants in health and disease" J Clin Pathol. 2001 Mar;54(3):176-86
26. Nie L. "Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production" Atherosclerosis 2006 Jun;186(2):260-6
27. Habauzit V. et al "Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians" Ther Adv Chronic Dis. 2012 Mar;3(2):87-106
28. Yang N. et al "Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?" Chin Med J (Engl). 2015 Sep 20;128(18):2530-4
29. Witkowski M. et al "Gut Microbiota and Cardiovascular Disease" Circ Res 2020 Jul 31;127(4):553-570
30. Marković A. "Vasculitis and vasculopathy" Acta Med Croatica. 2012 Oct;66 Suppl 1:19-24
31. Kinova S. et al "Carcinoid tumor" Bratisl Lek Listy. 2001;102(11):495-504
32. Maroun J. et al "Guidelines for the diagnosis . A statement from a Canadian National Carcinoid Expert Groupand management of carcinoid tumours. Part 1: the gastrointestinal tract. " Curr Oncol. 2006 Apr;13(2):67-76
33. Scott AT. et al "Management of Small Bowel Neuroendocrine Tumors" J Oncol Pract. 2018 Aug;14(8):471-482
34. Kusbeci OY. et al "Could Toxoplasma gondii have any role in Alzheimer disease?" Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):1-3
35. Murphy MP. et al "Alzheimer's disease and the amyloid-beta peptide" J Alzheimers Dis. 2010;19(1):311-23
36. Modarresi F. et al "Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis" Int J Alzheimers Dis. 2011;2011:929042
37. Taupin P. "Neurogenesis and Alzheimer's disease" Drug Target Insights. 2006;1:1-4
38. Hurt JK. et al "Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine" Plos one, 30 Oct 2012, 7(10):e48562
39. Lauretti E. et al "Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer's disease" Sci Rep. 2017 Dec 7;7(1):17134
40. Arellanes IC. et al "Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial" EBioMedicine 2020 Jul 17;102883
41. Miller AL. "The Methylation, Neurotransmitter, and Antioxidant Connections Between Folate and Depression" Altern Med Rev 2008 Sep;13(3):216-26
42. Liu L. et al "Herbal Medicine for Anxiety, Depression and Insomnia" Curr Neuropharmacol. 2015;13(4):481-93
43. Du X. et al "Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes" Diabetologia. 2008 Oct;51(10):1930-2
44. Frick PJ. et al "Current issues in the diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder" Annu Rev Clin Psychol. 2012;8:77-107
45. Rzepka-Migut B. et al "Efficacy and Safety of Melatonin Treatment in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder-A Review of the Literature" Brain Sci 2020 Apr 7;10(4):219
46. Julian LJ. "Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A)" Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
47. Liu L. et al "Herbal Medicine for Anxiety, Depression and Insomnia" Curr Neuropharmacol. 2015;13(4):481-93
48. Gilberts EC. et al "Molecular evidence for two forms of Crohn disease" Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12721-4
49. Kanne JP. et al "Eponyms in radiology of the digestive tract: historical perspectives and imaging appearances.
Part 2. Liver, biliary system, pancreas, peritoneum, and systemic disease" Radiographics Mar-Apr 2006;26(2):465-80
50. Smith JP. et al "Low-dose naltrexone therapy improves active Crohn's disease" Am J Gastroenterol. 2007 Apr;102(4):820-8
51. Benjamin J. et al "Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease" World J Gastroenterol. 2008 Mar 7;14(9):1399-405
52. Anderson CA. et al "Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47" Nat Genet. 2011 Mar;43(3):246-52
53. Benjamin J. et al "Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial" Dig Dis Sci. 2012 Apr;57(4):1000-12
54. Hameed AM. "Significant elevations of serum lipase not caused by pancreatitis: a systematic review" HPB (Oxford). 2015 Feb; 17(2): 99–112
55. Henke MT. "Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide" Proc Natl Acad Sci U S A 2019 Jun 25;116(26):12672-12677
56. Snider GL. "Nosology for our day: its application to chronic obstructive pulmonary disease" Am J Respir Crit Care Med. 2003 Mar 1;167(5):678-83
57. Mannam P. et al "Oxidants in Acute and Chronic Lung Disease" J Blood Lymph. 2014;4. pii: 1000128
58. Mitchell K. et al "Effects of dietary nitrate on respiratory physiology at high altitude - Results from the Xtreme Alps study" Nitric Oxide. 2017 Dec 1;71:57-68
59. Schmidt A. "Malassezia furfur: a fungus belonging to the physiological skin flora and its relevance in skin disorders" Cutis. 1997 Jan;59(1):21-4
60. Jansen PA. et al "Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines" J Invest Dermatol. 2009 Sep;129(9):2167-74
61. Lobito AA. et al "Murine insulin growth factor-like (IGFL) and human IGFL1 proteins are induced in inflammatory skin conditions and bind to a novel tumor necrosis factor receptor family member, IGFLR1" J Biol Chem. 2011 May 27;286(21):18969-81
62. Fu LW. et al "Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome" Dermatol Res Pract. 2011;2011:276079
63. Russell M. "Assessing the relationship between vitamin D3 and stratum corneum hydration for the treatment of xerotic skin" Nutrients 2012 Sep;4(9):1213-8
64. Cronstein BN. "Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis" Pharmacol Rev. 2005 Jun;57(2):163-72
65. Nazrun AS. et al "The anti-inflammatory role of vitamin e in prevention of osteoporosis" Adv Pharmacol Sci 2012;2012:142702
66. Takahashi Y. et al "Prophylactic and therapeutic effects of Acanthopanax senticosus Harms extract on murine collagen-induced arthritis" Phytother Res. 2014 Oct;28(10):1513-9
67. Kennedy PJ. et al "Irritable bowel syndrome: a microbiome-gut-brain axis disorder?" World J Gastroenterol. 2014 Oct 21;20(39):14105-25
68. Hawn TR. et al "A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus" Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10593-7
69. Fan Y. et al "The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta-analysis" Int J Immunogenet. 2011 Apr;38(2):151-9
70. Shiari R. "Neurologic manifestations of childhood rheumatic diseases" Iran J Child Neurol. 2012 Fall;6(4):1-7
71. Reynolds JA. et al "Vitamin D treatment for connective tissue diseases: hope beyond the hype?" Rheumatology (Oxford). 2017 Feb;56(2):178-186
72. Dalal JJ. et al "LIPITENSION: Interplay between dyslipidemia and hypertension" Indian J Endocrinol Metab. 2012 Mar;16(2):240-5
73. Choi MK. et al "Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in Korean adults: the Korea National Health and Nutrition Examination Survey (2007-2008)" Biol Trace Elem Res. 2013 Dec;156(1-3):56-66
74. Tartaglia MC. et al "Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up" Arch Neurol. 2007 Feb;64(2):232-6
75. Mann RH. "Impaired Thiamine Metabolism in Amyotrophic Lateral Sclerosis and Its Potential Treatment With Benfotiamine: A Case Report and a Review of the Literature" Cureus 2023 Jun 16;15(6):e40511
76. Takeuchi T. et al "Four clinical types of panic disorders" Jpn J Psychiatry Neurol 1992 Mar;46(1):37-44
77. Demiralay C. "Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?" Psychoneuroendocrinology 2017 Feb:76:14-18
78. Bahmer T. et al "Physical Activity and Fatigue in Patients with Sarcoidosis" Respiration. 2018;95(1):18-26
79. Evidente VG. "Is it a tic or Tourette's? Clues for differentiating simple from more complex tic disorders" Postgrad Med. 2000 Oct;108(5):175-6, 179-82
80. Lombroso PJ. et al "Tourette syndrome and obsessive-compulsive disorder" Brain Dev. 2008 Apr;30(4):231-7
81. Wenzel C. et al "Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients" J Clin Psychopharmacol. 2012 Aug;32(4):548-50
82. Ito H. et al "Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report" BMC Neurol. 2018 May 23;18(1):72
The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.